iRadimed Corp logo

iRadimed Corp

$ 28.32 -0.2 (-0.7%) 10:08 PM EST
P/E:
27.23
P/B:
5.10
Market Cap:
$ 355.88M
Enterprise V:
$ 305.08M
Volume:
30.84K
Avg Vol (2M):
26.99K
Also Trade In:
Volume:
30.84K
Market Cap $:
355.88M
PE Ratio:
27.23
Avg Vol (2-Month):
26.99K
Enterprise Value $:
305.08M
PB Ratio:
5.10
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.
Name Current Vs Industry Vs History
Cash-To-Debt 24.43
Equity-to-Asset 0.88
Debt-to-Equity 0.03
Debt-to-EBITDA 0.14
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 25.01
Distress
Grey
Safe
Beneish M-Score -1.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.87
9-Day RSI 44.19
14-Day RSI 46.21
6-1 Month Momentum % -10.09
12-1 Month Momentum % -29.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.83
Quick Ratio 11.89
Cash Ratio 9.92
Days Inventory 153.8
Days Sales Outstanding 50.69
Days Payable 30.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.5

Financials (Next Earnings Date:2023-02-03 Est.)

IRMD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IRMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 50.313
EPS (TTM) ($) 1.04
Beta 0.7
Volatility % 60.24
14-Day RSI 46.21
14-Day ATR ($) 1.574981
20-Day SMA ($) 28.781
12-1 Month Momentum % -29.39
52-Week Range ($) 26 - 55.92
Shares Outstanding (Mil) 12.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

iRadimed Corp Filings

Document Form Filing Date
No Filing Data

iRadimed Corp Analysis

Share your research

Headlines

See More
No news.